Our experiences in surgical treatment for hilar cholangiocarcinoma

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 669-673

  Maeno, Hiroshi ^a   Ono, Takashi ^a   Yamanoi, Akira ^a   Nagasue, Naofumi ^b  

^a SHIMANE UNIVERSITY   (Japan)

^b Fukumitsu Hospital   (Japan)

Author keywords

Hepatectomy; Hilar cholangiocarcinoma; Surgical treatment

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ABDOMINAL ABSCESS; ABDOMINAL BLEEDING; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIARY TRACT SURGERY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; MEDICAL ASSESSMENT; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34250215232     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
2. Nimura Y, Kamiya J, Kondo S, et al: Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat Surg 2000; 7:155-162.
3. Tsao JI, Nimura Y, Kamiya J, et al: Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 2000; 232:166-174.
4. Furukawa H, Sano K, Kosuge T, et al: Hilar cholangiocarcinoma evaluated by three-dimensional CT cholangiography and rotating cine cholangiography. Hepatogastroenterology 2000; 47:615-620.
5. Klempnauer J, Ridder GJ, von Wasielewski R, et al: Resectional surgery of hilar cholangiocarcinoma: a multivariate analysis of prognostic factors. J Clin Oncol 1997; 15:947-954.
6. Hadjis NS, Blenkharn JI, Alexander N, et al: Outcome of radical surgery in hilar cholangiocarcinoma. Surgery 1990; 107:597-604.
7. Capussotti L, Muratore A, Polastri R, et al: Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival. J Am Coll Surg 2002; 195:641-647.
8. Havlik R, Sbisa E, Tullo A, et al: Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology 2000; 47:927-931.
9. Gerhards MF, van Gulik TM, Gonzalez Gonzalez D, et al: Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003; 27:173-179.
10. Bengmark S, Ekberg H, Evander A, et al: Major liver resection for hilar cholangiocarcinoma. Ann Surg 1988; 207:120-125.
11. Kosuge T, Yamamoto J, Shimada K, et al: Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999; 230:663-671.
12. Miyazaki M, Ito H, Nakagawa K, et al: Hepatectomy (parenchyma-preserving) for hilar cholangiocarcinoma Nippon Geka Gakkai Zasshi 2000; 101:413-417. (In Japanese)
13. Kawarada Y, Das BC, Naganuma T, et al: Surgical treatment of hilar bile duct carcinoma: experience with 25 consecutive hepatectomies. J Gastrointest Surg 2002; 6:617-624.
14. Shinchi H, Takao S, Nishida H, et al: Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma. J Surg Oncol 2000; 75:89-94.
15. Ratricia D G, Lee D H, Peter A.S. J: Palliation of unresectable hilar cholangiocarcinoma. J Surg Oncol 2000; 75:95-97.
16. Nagino M, Kamiya J, Uesaka K, et al: Complications of hepatectomy for hilar cholangiocarcinoma. World J Surg 2001; 25:1277-1283.
17. Shimada H, Endo I, Fujii Y, et al: Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma. Hepatogastroenterology 2002; 49:300-305.
18. Jarnagin WR, Fong Y, DeMatteo RP, et al: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-519
19. Su CH, Tsay SH, Wu CC, et al: Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223:384-394.
20. Gerhards MF, van Gulik TM, de Wit LT,et al: Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma - a single center experience. Surgery 2000; 127:395-404.
21. Nimura Y, Kamiya J, Nagino M, et al: Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 1998; 5:52-61.
22. Franco D, Usatoff V: Surgery for cholangiocarcinoma. Hepatogastroenterology 2001; 48:53-55.
23. Bathe OF, Pacheco JT, Ossi PB, et al: Management of hilar bile duct carcinoma. Hepatogastroenterology 2001; 48:1289-1294.
24. Kawarada Y, Das BC, Onishi H, et al: Surgical anatomy of the bile duct branches of the medial segment (B4) of the liver in relation to hilar carcinoma. J Hepatobiliary Pancreat Surg 2000; 7:480-485.
25. Lillemoe KD, Cameron JL: Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary Pancreat Surg 2000; 7:115-121.
26. Jarnagin WR, Fong Y, DeMatteo RP, et al: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234:507-517.